Literature DB >> 26136925

Effect of osteopontin on the mRNA expression of ADAMTS4 and ADAMTS5 in chondrocytes from patients with knee osteoarthritis.

Shu-Guang Gao1, Chao Zeng2, Yang Song3, Jian Tian2, Chao Cheng2, Tuo Yang2, Hui Li2, Fang-Jie Zhang2, Guang-Hua Lei1.   

Abstract

Previous studies have demonstrated that osteopontin (OPN) levels are elevated in the synovial fluid and articular cartilage, and are associated with the severity of knee osteoarthritis (OA). However, the role of OPN in the pathogenesis of OA has yet to be elucidated. The present study aimed to investigate the effects of OPN on the expression of the aggrecanases, a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)4 and ADAMTS5, in human OA chondrocytes, as they serve a key function in aggrecan degradation. Human OA chondrocytes were obtained from the knees of 16 patients with OA, and subsequently cultured in a monolayer. The chondrocytes were divided into three groups, which included the control (no treatment), N-OPN (treated with 100 ng/ml OPN, the normal circulating OPN concentration) and the H-OPN groups (treated with 1 µg/ml OPN, a high OPN concentration). Reverse transcription-quantitative polymerase chain reaction was performed to quantify the relative mRNA expression levels of ADAMTS4, ADAMTS5 and aggrecan in the chondrocytes. The mRNA expression levels of ADAMTS4 were significantly reduced in the N-OPN and H-OPN groups when compared with the control group (P<0.0001). In addition, the mRNA expression levels of ADAMTS4 were lower in the H-OPN group when compared with the N-OPN group (P<0.001). However, no statistically significant difference was observed in the relative mRNA expression levels of ADAMTS5 among the three groups (P>0.05). Furthermore, the mRNA expression levels of aggrecan were higher in the N-OPN and H-OPN groups when compared with the control group (P<0.0001), and a statistically significant difference was observed between the N-OPN and H-OPN groups with regard to the mRNA expression of aggrecan (P<0.0001). These results demonstrated that OPN may exert a protective effect in human OA chondrocytes against aggrecan degradation by suppressing the expression of ADAMTS4.

Entities:  

Keywords:  a disintegrin and metalloproteinase with thrombospondin motifs 4; a disintegrin and metalloproteinase with thrombospondin motifs 5; aggrecan; osteoarthritis; osteopontin

Year:  2015        PMID: 26136925      PMCID: PMC4471803          DOI: 10.3892/etm.2015.2310

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  36 in total

1.  Osteopontin is expressed by adult human osteoarthritic chondrocytes: protein and mRNA analysis of normal and osteoarthritic cartilage.

Authors:  O Pullig; G Weseloh; S Gauer; B Swoboda
Journal:  Matrix Biol       Date:  2000-07       Impact factor: 11.583

2.  Osteopontin induction of hyaluronan synthase 2 expression promotes breast cancer malignancy.

Authors:  Amy C Cook; Ann F Chambers; Eva A Turley; Alan B Tuck
Journal:  J Biol Chem       Date:  2006-06-28       Impact factor: 5.157

3.  Usefulness of specific OA biomarkers, thrombin-cleaved osteopontin, in the posterior cruciate ligament OA rabbit model.

Authors:  S G Gao; L Cheng; C Zeng; L C Wei; F J Zhang; J Tian; M Tu; W Luo; G H Lei
Journal:  Osteoarthritis Cartilage       Date:  2012-09-28       Impact factor: 6.576

4.  The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation.

Authors:  M D Tortorella; A M Malfait; C Deccico; E Arner
Journal:  Osteoarthritis Cartilage       Date:  2001-08       Impact factor: 6.576

5.  Osteopontin: an intrinsic inhibitor of inflammation in cartilage.

Authors:  M G Attur; M N Dave; S Stuchin; A J Kowalski; G Steiner; S B Abramson; D T Denhardt; A R Amin
Journal:  Arthritis Rheum       Date:  2001-03

Review 6.  Role of osteopontin in regulating hepatic inflammatory responses and toxic liver injury.

Authors:  Shashi K Ramaiah; Susan Rittling
Journal:  Expert Opin Drug Metab Toxicol       Date:  2007-08       Impact factor: 4.481

7.  Deficiency of tenascin-C delays articular cartilage repair in mice.

Authors:  N Okamura; M Hasegawa; Y Nakoshi; T Iino; A Sudo; K Imanaka-Yoshida; T Yoshida; A Uchida
Journal:  Osteoarthritis Cartilage       Date:  2009-09-06       Impact factor: 6.576

8.  Elevated osteopontin level of synovial fluid and articular cartilage is associated with disease severity in knee osteoarthritis patients.

Authors:  S G Gao; K H Li; K B Zeng; M Tu; M Xu; G H Lei
Journal:  Osteoarthritis Cartilage       Date:  2009-09-01       Impact factor: 6.576

9.  Elevated plasma osteopontin level is associated with occurrence of psoriasis and is an unfavorable cardiovascular risk factor in patients with psoriasis.

Authors:  Yi-Ju Chen; Jui-Lung Shen; Chun-Ying Wu; Yun-Ting Chang; Chuan-Mu Chen; Fang-Yi Lee
Journal:  J Am Acad Dermatol       Date:  2008-11-25       Impact factor: 11.527

10.  Osteopontin-mediated enhanced hyaluronan binding induces multidrug resistance in mesothelioma cells.

Authors:  K Tajima; R Ohashi; Y Sekido; T Hida; T Nara; M Hashimoto; S Iwakami; K Minakata; T Yae; F Takahashi; H Saya; K Takahashi
Journal:  Oncogene       Date:  2010-01-18       Impact factor: 9.867

View more
  10 in total

1.  Osteopontin stimulates matrix metalloproteinase expression through the nuclear factor-κB signaling pathway in rat temporomandibular joint and condylar chondrocytes.

Authors:  Feng Ding; Jing Wang; Guoxiong Zhu; Huaqiang Zhao; Gaoyi Wu; Lei Chen
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

2.  The lncRNA MIAT/miR-181a-5p axis regulates osteopontin (OPN)-mediated proliferation and apoptosis of human chondrocytes in osteoarthritis.

Authors:  Suolin Zeng; Min Tu
Journal:  J Mol Histol       Date:  2022-03-14       Impact factor: 2.611

3.  Genetic association analysis of Osteopontin and Matrix Gla Protein genes polymorphisms with primary knee osteoarthritis in Mexican population.

Authors:  Verónica Marusa Borgonio-Cuadra; Norma Celia González-Huerta; Emma Xochitl Rojas-Toledo; Eugenio Morales-Hernández; Nonanzit Pérez-Hernández; José Manuel Rodríguez-Pérez; Carlos Alfonso Tovilla-Zárate; Thelma Beatriz González-Castro; Yazmín Hernández-Díaz; María Lilia López-Narváez; Antonio Miranda-Duarte
Journal:  Clin Rheumatol       Date:  2018-05-18       Impact factor: 2.980

4.  The miR-302c/transforming growth factor-β receptor type-2 axis modulates interleukin-1β-induced degenerative changes in osteoarthritic chondrocytes.

Authors:  Yiyue Chen; You Chen; Wanchun Wang; Junhua Chen; Qi Tang; Ren Wu; Weihong Zhu; Ding Li; Lele Liao
Journal:  J Cell Commun Signal       Date:  2021-06-14       Impact factor: 5.782

5.  Strontium ranelate causes osteophytes overgrowth in a model of early phase osteoarthritis.

Authors:  Jian-Guo Chu; Mu-Wei Dai; Yu Wang; Fa-Ming Tian; Hui-Ping Song; Ya-Ping Xiao; Li-Tao Shao; Ying-Ze Zhang; Liu Zhang
Journal:  BMC Musculoskelet Disord       Date:  2017-02-10       Impact factor: 2.362

6.  Interrelationship of Osteopontin, MMP-9 and ADAMTS4 in Patients With Osteoarthritis Undergoing Total Joint Arthroplasty.

Authors:  Hannah Slovacek; Rajan Khanna; Pavel Poredos; Mateja Jezovnik; Debra Hoppensteadt; Jawed Fareed; William Hopkinson
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

7.  MicroRNA-127-5p regulates osteopontin expression and osteopontin-mediated proliferation of human chondrocytes.

Authors:  Min Tu; Yusheng Li; Chao Zeng; Zhenhan Deng; Shuguang Gao; Wenfeng Xiao; Wei Luo; Wei Jiang; Liangjun Li; Guanghua Lei
Journal:  Sci Rep       Date:  2016-04-29       Impact factor: 4.379

8.  Osteopontin Promotes Expression of Matrix Metalloproteinase 13 through NF-κB Signaling in Osteoarthritis.

Authors:  Yusheng Li; Wei Jiang; Hua Wang; Zhenhan Deng; Chao Zeng; Min Tu; Liangjun Li; Wenfeng Xiao; Shuguang Gao; Wei Luo; Guanghua Lei
Journal:  Biomed Res Int       Date:  2016-08-30       Impact factor: 3.411

9.  LINC00623/miR-101/HRAS axis modulates IL-1β-mediated ECM degradation, apoptosis and senescence of osteoarthritis chondrocytes.

Authors:  Guohua Lü; Lei Li; Bing Wang; Lei Kuang
Journal:  Aging (Albany NY)       Date:  2020-02-12       Impact factor: 5.682

10.  OPN Deficiency Increases the Severity of Osteoarthritis Associated with Aberrant Chondrocyte Senescence and Apoptosis and Upregulates the Expression of Osteoarthritis-Associated Genes.

Authors:  Jian Tian; Chao Cheng; Shi-Da Kuang; Chao Su; Xin Zhao; Yi-Lin Xiong; Yu-Sheng Li; Shu-Guang Gao
Journal:  Pain Res Manag       Date:  2020-10-22       Impact factor: 3.037

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.